Personalized Tumor Vaccines and Pabolizumab in Patients With Advanced Pancreatic Cancer
Clinical trial NCT05916261 · RECRUITING
Trial details
- NCT number
- NCT05916261
- Sponsor
- Ruijin Hospital
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-26
- Primary completion
- 2026-11-30
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.